Back to Search
Start Over
Soluble urokinase plasminogen activator receptor (suPAR) as a biomarker of early pregnancy location and viability compared with hCG, progesterone and estradiol.
- Source :
-
Journal of reproductive immunology [J Reprod Immunol] 2020 Apr; Vol. 138, pp. 103103. Date of Electronic Publication: 2020 Feb 15. - Publication Year :
- 2020
-
Abstract
- A circulating biomarker of early pregnancy outcome independent of ultrasonography and gestational age is a coveted goal. This study evaluated soluble urokinase plasminogen activator receptor (suPAR), a well-described marker of inflammation and immunological activation, for this purpose, and compared it with established early pregnancy biomarkers of the luteoplacental phase: progesterone, estradiol and hCG. We merged data from two prospective first trimester cohorts to conduct a case-control study comparing these analytes in women who had either a live birth, a miscarriage or an ectopic pregnancy. The ability to predict pregnancy location and viability was assessed by areas under the receiver operating characteristic curves (AUC). Comparing women irrespective of gestational age with a live birth, miscarriage or ectopic pregnancy showed significantly lower suPAR values in the latter group (2.4 vs. 2.4 vs. 2.0 μg/L, p = 0.032, respectively), as were all other analytes. Before 6 weeks' gestation, suPAR was significantly inferior to progesterone, estradiol and hCG in pregnancy location and viability prediction (in 124 pregnancies, suPAR AUC <subscript>location</subscript> = 0.69 [CI: 0.54-0.83] and AUC <subscript>viability</subscript> = 0.58 [CI: 0.48-0.69], while progesterone AUC <subscript>location</subscript> = 0.95 [CI: 0.87-1.00] and AUC <subscript>viability</subscript> = 0.84 [CI: 0.75-0.92]). After 6 weeks' gestation, suPAR prediction improved but was inferior to hCG, progesterone and estradiol (in 188 pregnanices, suPAR AUC <subscript>location</subscript> = 0.71 [CI: 0.63-0.78] and AUC <subscript>viability</subscript> = 0.70 [CI: 0.63-0.78] compared with hCG AUC <subscript>location</subscript> = 0.96 [CI: 0.93-0.99] and AUC <subscript>viability</subscript> = 0.96 [CI: 0.93-0.98]). Collectively, suPAR is less useful as a predictor of early pregnancy outcome than hCG, progesterone and estradol.<br />Competing Interests: Declaration of Competing Interest Outside the submitted work Anders Nyboe Andersen reports grants and personal fees from Ferring, MSD and Gedeon-Richter and personal fees and honoraria from Merck Serono, MSD, Novo-Nordisk and Abbott. All other authors declare no conflict of interest.<br /> (Copyright © 2020 Elsevier B.V. All rights reserved.)
- Subjects :
- Abortion, Spontaneous blood
Abortion, Spontaneous immunology
Adult
Biomarkers blood
Case-Control Studies
Chorionic Gonadotropin blood
Denmark epidemiology
Estradiol blood
Feasibility Studies
Female
Humans
Inflammation blood
Inflammation diagnosis
Inflammation immunology
Live Birth
Predictive Value of Tests
Pregnancy
Pregnancy Outcome
Pregnancy Trimester, First
Pregnancy, Ectopic blood
Pregnancy, Ectopic immunology
Progesterone blood
Prospective Studies
ROC Curve
Risk Assessment methods
Young Adult
Abortion, Spontaneous epidemiology
Pregnancy, Ectopic diagnosis
Receptors, Urokinase Plasminogen Activator blood
Subjects
Details
- Language :
- English
- ISSN :
- 1872-7603
- Volume :
- 138
- Database :
- MEDLINE
- Journal :
- Journal of reproductive immunology
- Publication Type :
- Academic Journal
- Accession number :
- 32145561
- Full Text :
- https://doi.org/10.1016/j.jri.2020.103103